SCHEMBL27697776

SCHEMBL27697776

NC(=O)Cc1cccc(CCC(=O)O)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KEAP1 Q14145 1/20 0.57
▸ PTPRB P23467 1/20 0.54
▸ CDC25A P30304 1/20 0.54
▸ CDC25B P30305 1/20 0.54
▸ PTEN P60484 1/20 0.54
▸ PTPMT1 Q8WUK0 1/20 0.54
▸ FFAR1 O14842 6/20 0.53
▸ SIRT1 Q96EB6 1/20 0.50
▸ ITGB3 P05106 1/20 0.49
▸ ITGA2B P08514 1/20 0.49
▸ PLA2G10 O15496 6/20 0.48
▸ PLA2G2A P14555 1/20 0.48
▸ SLCO1B1 Q9Y6L6 1/20 0.48
▸ TBXA2R P21731 1/20 0.46
▸ HDAC3 O15379 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ ADRA1A P35348 1/20 0.44
▸ HDAC4 P56524 1/20 0.44
▸ SLC6A3 Q01959 1/20 0.44
▸ HDAC1 Q13547 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4407150 0.87 KEAP1 (0.63) KEAP1PTPRBCDC25ACDC25BPTEN
SCHEMBL30638471 0.87 KEAP1 (0.63) KEAP1PTPRBCDC25ACDC25BPTEN
SCHEMBL70271 0.87 KEAP1 (0.74) KEAP1PTPRBCDC25ACDC25BPTEN
SCHEMBL21728869 0.85 AKR1B1 (0.58) ITGB3ITGA2BPLA2G10PLA2G2A
Hydrochloric Acid SCHEMBL10982620 0.85 KEAP1 (0.71) KEAP1PTPRBCDC25ACDC25BPTEN
SCHEMBL10339219 0.84 CA2 (0.54) MAPK1
SCHEMBL18798802 0.82 LMNA (0.50) HDAC3MAPK1ADRA1AHDAC4SLC6A3
SCHEMBL2016247 0.81 KEAP1 (0.61) KEAP1PTPRBCDC25ACDC25BPTEN
SCHEMBL31273986 0.81 KEAP1 (0.61) KEAP1PTPRBCDC25ACDC25BPTEN
SCHEMBL5264276 0.81 KEAP1 (0.61) KEAP1PTPRBCDC25ACDC25BPTEN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4658667-A1 CYCLIC PEPTIDES FOR INHIBITING TNF RECEPTOR 1 ACTIVITY Merck Sharp & Dohme LLC (US) 2025-12-10 — — EP disclosed
WO-2024163691-A1 CYCLIC PEPTIDES FOR INHIBITING TNF RECEPTOR 1 ACTIVITY MERCK SHARP & DOHME LLC (US) 2024-08-08 — — WO disclosed
CN-102083432-A Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals SANOFI AVENTIS 2011-06-01 — — CN disclosed
CN-85101711-A The preparation new cephalosporins and process for their — 1987-01-31 — — CN disclosed
Send feedback